Technical Analysis for PRTO - Proteon Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
PRTO closed up 1.54 percent on Friday, January 18, 2019, on 35 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical PRTO trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 18||Up 3 Days in a Row||Strength||0.00%|
|Jan 18||Up 4 Days in a Row||Strength||0.00%|
|Jan 17||Volume Surge||Other||1.54%|
|Jan 17||Doji - Bearish?||Reversal||1.54%|
|Jan 17||Stochastic Reached Overbought||Strength||1.54%|
|Jan 17||Wide Bands||Range Expansion||1.54%|
|Jan 17||Overbought Stochastic||Strength||1.54%|
|Jan 17||Up 3 Days in a Row||Strength||1.54%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Proteon Therapeutics, Inc., a biopharmaceutical company, develops pharmaceuticals to treat renal and vascular diseases. The company is developing PRT-201, a recombinant human elastase, which is in Phase III clinical trials for the treatment of radiocephalic arteriovenous fistula; and has completed a Phase I/II trial for the treatment of patients undergoing surgical placement of an arteriovenous graft. The company was founded in 2001 and is based in Waltham, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PRTO news...
|52 Week High||2.9|
|52 Week Low||1.5|
|200-Day Moving Average||2.1549|
|50-Day Moving Average||1.9761|
|20-Day Moving Average||2.3275|
|10-Day Moving Average||2.541|
|Average True Range||0.1267|
|Chandelier Exit (Long, 3 ATRs )||2.3099|
|Chandelier Exit (Short, 3 ATRs )||2.1401|
|Upper Bollinger Band||2.9078|
|Lower Bollinger Band||1.7472|
|Percent B (%b)||0.77|
|MACD Signal Line||0.1826|
|Market Cap||46.52 Million|
|Num Shares||17.6 Million|
|Price-to-Earnings (P/E) Ratio||-1.69|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||2.79|
|Resistance 3 (R3)||2.78||2.71||2.77|
|Resistance 2 (R2)||2.71||2.68||2.72||2.76|
|Resistance 1 (R1)||2.68||2.65||2.70||2.69||2.75|
|Support 1 (S1)||2.58||2.58||2.60||2.59||2.53|
|Support 2 (S2)||2.51||2.55||2.52||2.52|
|Support 3 (S3)||2.48||2.51||2.52|
|Support 4 (S4)||2.49|